Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Mar 6, 2024 | Horse | Horse (unknown) | MSK | Injection site hair change | Outcome Unknown |
| Mar 6, 2024 | Horse | Standardbred (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Mar 6, 2024 | Horse | Warmblood (unspecified) | MSK | Slow heart rate; Pale mucous membrane; Colic; Elevated total bilirubin; Abdom... | Outcome Unknown |
| Mar 5, 2024 | Horse | Quarter Horse | MSK | Injection site swelling; Fasciculation | Outcome Unknown |
| Mar 4, 2024 | Horse | Warmblood (unspecified) | MSK | Pawing; Increased sweating; Disorientation; Colic | Ongoing |
| Mar 4, 2024 | Horse | Mustang | MSK | Lethargy (see also Central nervous system depression in Neurological); Reluct... | Outcome Unknown |
| Mar 3, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS; Other abnormal test result NOS | Outcome Unknown |
| Mar 3, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Mar 2, 2024 | Horse | Horse (unknown) | MSK | Local swelling (not application site); Skin warmth; Swollen limb; Localised p... | Recovered/Normal |
| Mar 1, 2024 | Horse | Horse (unknown) | MSK | INEFFECTIVE, GASTRIC ULCER(S) | Outcome Unknown |
| Mar 1, 2024 | Horse | Tennessee Walking Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Mar 1, 2024 | Horse | Pony (unspecified) | MSK | Hair change; Lethargy (see also Central nervous system depression in Neurolog... | Outcome Unknown |
| Mar 1, 2024 | Horse | Horse (unknown) | MSK | Injection site joint reaction | Outcome Unknown |
| Mar 1, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Mar 1, 2024 | Horse | Saddlebred - American | MSK | Lack of efficacy - NOS | Ongoing |
| Mar 1, 2024 | Horse | Unknown | MSK | Joint swelling; No sign | Outcome Unknown |
| Mar 1, 2024 | Horse | Quarter Horse | MSK | Diarrhoea; Localised rash; Weakness; Difficulty to rise | Outcome Unknown |
| Feb 29, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Feb 29, 2024 | Horse | Horse (unknown) | MSK | Anorexia; Anaemia NOS; Low platelet count; Trembling; Loose stool; Listless; ... | Ongoing; Recovered/Normal |
| Feb 27, 2024 | Horse | Warmblood (unspecified) | MSK | Fever; Heavy sweating; Shaking; Pacing; Colic; Enlarged lymph node (localised) | Recovered/Normal |
| Feb 27, 2024 | Horse | Quarter Horse | MSK | Injection site abscess | Recovered/Normal |
| Feb 26, 2024 | Horse | Thoroughbred | MSK | Swollen limb; Pyrexia; Skin slough; Cutaneous oedema | Ongoing |
| Feb 26, 2024 | Horse | Quarter Horse | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy | Ongoing |
| Feb 24, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Feb 23, 2024 | Horse | Arab, Horse (unknown) | MSK | Tarry or black stool (see also haemorrhagic diarrhoea); Anorexia; Application... | Outcome Unknown |
| Feb 23, 2024 | Horse | Unknown | MSK | Death | Died |
| Feb 22, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Feb 22, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Feb 21, 2024 | Horse | Warmblood - Dutch | MSK | Lack of efficacy - NOS | Ongoing |
| Feb 20, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Feb 20, 2024 | Horse | Quarter Horse | MSK | Ataxia | Ongoing |
| Feb 20, 2024 | Horse | Quarter Horse | MSK | Hepatitis | Ongoing |
| Feb 20, 2024 | Horse | Paint | MSK | Head bobbing | Recovered/Normal |
| Feb 20, 2024 | Horse | Paint | MSK | Head bobbing; Underdose | Recovered/Normal |
| Feb 18, 2024 | Horse | Connemara Pony | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Feb 18, 2024 | Horse | Horse (other) | MSK | Hair coat discolouration; Injection site hair change | Outcome Unknown |
| Feb 18, 2024 | Horse | Quarter Horse | MSK | Rubbing; Hyperactivity; Hives (see also Skin); Hypersensitivity reaction | Recovered/Normal |
| Feb 17, 2024 | Horse | Quarter Horse | MSK | Agitation; Muscle spasm NOS | Recovered/Normal |
| Feb 16, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Feb 15, 2024 | Horse | Quarter Horse | MSK | Epistaxis (unilateral) | Outcome Unknown |
| Feb 15, 2024 | Horse | Quarter Horse | MSK | Injection site swelling | Recovered/Normal |
| Feb 14, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Feb 13, 2024 | Horse | Thoroughbred | MSK | INEFFECTIVE, SEDATION | Recovered/Normal |
| Feb 13, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Feb 13, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Feb 13, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Feb 13, 2024 | Horse | Quarter Horse | MSK | Lethargy (see also Central nervous system depression in Neurological); Not ea... | Outcome Unknown |
| Feb 12, 2024 | Horse | Quarter Horse | MSK | Injection site inflammation | Ongoing |
| Feb 12, 2024 | Horse | Quarter Horse | MSK | Injection site alopecia | Outcome Unknown |
| Feb 12, 2024 | Horse | Welsh Cob | MSK | Lack of efficacy - NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.